BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23942367)

  • 1. Measuring α4β2* nicotinic acetylcholine receptor density in vivo with [(18)F]nifene PET in the nonhuman primate.
    Hillmer AT; Wooten DW; Slesarev MS; Ahlers EO; Barnhart TE; Schneider ML; Mukherjee J; Christian BT
    J Cereb Blood Flow Metab; 2013 Nov; 33(11):1806-14. PubMed ID: 23942367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey.
    Hillmer AT; Wooten DW; Moirano JM; Slesarev M; Barnhart TE; Engle JW; Nickles RJ; Murali D; Schneider ML; Mukherjee J; Christian BT
    Synapse; 2011 Dec; 65(12):1309-18. PubMed ID: 21674627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging of α4β2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate.
    Hillmer AT; Wooten DW; Slesarev MS; Ahlers EO; Barnhart TE; Murali D; Schneider ML; Mukherjee J; Christian BT
    J Nucl Med; 2012 Sep; 53(9):1471-80. PubMed ID: 22851633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate.
    Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    Nucl Med Biol; 2006 Apr; 33(3):295-304. PubMed ID: 16631077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human brain imaging of nicotinic acetylcholine α4β2* receptors using [
    Mukherjee J; Lao PJ; Betthauser TJ; Samra GK; Pan ML; Patel IH; Liang C; Metherate R; Christian BT
    J Comp Neurol; 2018 Jan; 526(1):80-95. PubMed ID: 28875553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic acetylcholine receptors in rat forebrain that bind ¹⁸F-nifene: relating PET imaging, autoradiography, and behavior.
    Bieszczad KM; Kant R; Constantinescu CC; Pandey SK; Kawai HD; Metherate R; Weinberger NM; Mukherjee J
    Synapse; 2012 May; 66(5):418-34. PubMed ID: 22213342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human biodistribution and dosimetry of [
    Betthauser TJ; Hillmer AT; Lao PJ; Ehlerding E; Mukherjee J; Stone CK; Christian BT
    Nucl Med Biol; 2017 Dec; 55():7-11. PubMed ID: 28963927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of lobeline on α4β2* nicotinic acetylcholine receptor binding and uptake of [(18)F]nifene in rats.
    Hillmer AT; Wooten DW; Farhoud M; Barnhart TE; Mukherjee J; Christian BT
    J Neurosci Methods; 2013 Apr; 214(2):163-9. PubMed ID: 23370310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Lao PJ; Betthauser TJ; Tudorascu DL; Barnhart TE; Hillmer AT; Stone CK; Mukherjee J; Christian BT
    Synapse; 2017 Aug; 71(8):. PubMed ID: 28420041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
    Easwaramoorthy B; Pichika R; Collins D; Potkin SG; Leslie FM; Mukherjee J
    Synapse; 2007 Jan; 61(1):29-36. PubMed ID: 17068780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET.
    Pichika R; Kuruvilla SA; Patel N; Vu K; Sinha S; Easwaramoorthy B; Narayanan TK; Shi B; Christian B; Mukherjee J
    Nucl Med Biol; 2013 Jan; 40(1):117-25. PubMed ID: 23141552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal [
    Liang C; Nguyen GA; Danh TB; Sandhu AK; Melkonyan LL; Syed AU; Mukherjee J
    Synapse; 2023 May; 77(3):e22265. PubMed ID: 36749986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine).
    Pichika R; Easwaramoorthy B; Christian BT; Shi B; Narayanan TK; Collins D; Mukherjee J
    Nucl Med Biol; 2011 Nov; 38(8):1183-92. PubMed ID: 21831652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
    Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
    Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor binding.
    Hillmer AT; Wooten DW; Farhoud M; Higgins AT; Lao PJ; Barnhart TE; Mukherjee J; Christian BT
    Synapse; 2013 Dec; 67(12):882-6. PubMed ID: 23913347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
    Wong DF; Kuwabara H; Kim J; Brasic JR; Chamroonrat W; Gao Y; Valentine H; Willis W; Mathur A; McCaul ME; Wand G; Gean EG; Dannals RF; Horti AG
    J Nucl Med; 2013 Aug; 54(8):1308-14. PubMed ID: 23801676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate.
    Wooten DW; Hillmer AT; Moirano JM; Tudorascu DL; Ahlers EO; Slesarev MS; Barnhart TE; Mukherjee J; Schneider ML; Christian BT
    Neuroimage; 2013 Aug; 77():125-32. PubMed ID: 23537936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the α4β2* nicotinic acetylcholine system during chronic controlled alcohol exposure in nonhuman primates.
    Hillmer AT; Tudorascu DL; Wooten DW; Lao PJ; Barnhart TE; Ahlers EO; Resch LM; Larson JA; Converse AK; Moore CF; Schneider ML; Christian BT
    Drug Alcohol Depend; 2014 May; 138():216-9. PubMed ID: 24602361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.